Finance

Lists
ALKEM:NSE
आलकेम ल्याबरोटरीज
₹ ५,३२०.००
-०.५७%
(-३०.५०) 1D
अक्टोबर ८, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
₹ ५,४०७.००
High
₹ ५,४०७.००
Low
₹ ५,२३७.५०
Mkt. cap
६.२७ खरब
Avg. vol.
१.४९ लाख
Volume
२.८१ लाख
Dividend
१.००%
Quarterly dividend
₹ १३.२५
Ex-dividend date
२०२६ अगस्ट ७
P/E ratio
२९.४८
52-wk high
₹ ५,९३३.५०
52-wk low
₹ ५,०५१.००
EPS
₹ १८०.४५
Shares outstanding
११.९६ करोड
No. of employees
१९ हजार
Open
₹ ५,४०७.००
High
₹ ५,४०७.००
Low
₹ ५,२३७.५०
Mkt. cap
६.२७ खरब
Avg. vol.
१.४९ लाख
Volume
२.८१ लाख
Dividend
१.००%
Quarterly dividend
₹ १३.२५
Ex-dividend date
२०२६ अगस्ट ७
P/E ratio
२९.४८
52-wk high
₹ ५,९३३.५०
52-wk low
₹ ५,०५१.००
EPS
₹ १८०.४५
Shares outstanding
११.९६ करोड
No. of employees
१९ हजार
News stories
From web sources and news partners
The Lufkin Daily News
The Lufkin Daily News
·
५५ मिनेट पहिले
FILE PHOTO: Traders react to the Fed rate announcement on the floor of the NYSE in New York
24/7 Wall St.
24/7 Wall St.
·
४ मिनेट पहिले
3 Stocks That Have More Than Doubled the S&P 500’s Return This Year
Yahoo Finance
Yahoo Finance
·
१९ मिनेट पहिले
Dell Turned $1,000 Into $11,641 in Five Years as AI Servers Crushed the S&P 500
Bloomberg.com
Bloomberg.com
·
१ घण्टा पहिले
AI Bubble Risks Worst S&P 500 Crash Since 2008, Strategist Says
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About आलकेम ल्याबरोटरीज
CEO-
Employees१९.३ हजार
Founded१९७३
Headquartersमुम्बई, महाराष्ट्र, भारत
Sector-
Last report
२०२६ अगस्ट १४
Fiscal period
Q1 2027
EPS / Est. (INR)
₹ ४३.४९ / ₹ ४७.०४
-७.५६%miss
Revenue / Est. (INR)
३७.४० अरब / ३७.९६ अरब
-१.४६%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४०.०१ अरब
३७.३७ अरब
३६.०३ अरब
३७.४० अरब
Cost of goods sold
१४.०१ अरब
१२.७३ अरब
१४.३३ अरब
१२.०१ अरब
Cost of revenue
१४.०१ अरब
१२.७३ अरब
१४.३३ अरब
१२.०१ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७.१० अरब
७.२२ अरब
१७.१२ अरब
८.०९ अरब
Operating expense
१७.७३ अरब
१७.३१ अरब
१७.८० अरब
१८.७३ अरब
Total operating expenses
३१.७४ अरब
३०.०४ अरब
३२.१३ अरब
३०.७४ अरब
Operating income
८.२७ अरब
७.३३ अरब
३.९० अरब
६.६६ अरब
Other non operating income
१.०४ अरब
१.४३ अरब
-३.५५ अरब
१.५३ अरब
EBT including unusual items
८.९५ अरब
७.८१ अरब
४.२२ अरब
७.७१ अरब
EBT excluding unusual items
८.९५ अरब
८.३३ अरब
४.७७ अरब
७.७१ अरब
Income tax expense
१.१६ अरब
१.२८ अरब
१.७१ अरब
२.५० अरब
Effective tax rate
१२.९८%
१६.३५%
४०.५३%
३२.४७%
Other operating expenses
९.६९ अरब
९.१५ अरब
-३७.८७ करोड
९.६४ अरब
Net income
७.६५ अरब
६.३६ अरब
२.३६ अरब
५.२० अरब
Net profit margin
१९.१२%
१७.०२%
६.५६%
१३.९०%
Earnings per share
६३.९९
५६.८८
२६.५०
४३.४९
Interest and investment income
-
-
३.९२ अरब
-
Interest expense
-३५.०२ करोड
-४२.१० करोड
-३३.६५ करोड
-४६.६२ करोड
Net interest expenses
-३५.०२ करोड
-४२.१० करोड
३.५८ अरब
-४६.६२ करोड
Depreciation and amortization charges
९३.६१ करोड
९५.०१ करोड
१.०६ अरब
१.०० अरब
EBITDA
९.१८ अरब
८.११ अरब
४.६७ अरब
७.४३ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू